The key ideas

Outlive: The Science and Art of Longevity

Peter Attia, Bill Gifford, 2023

Why do we treat disease only when it is too late? Physician Peter Attia shows that the four major diseases of our time take decades to develop, and that each of us has levers to push them back. You will learn why endurance matters more than any diet, and how to start preparing for the last decade of your life right now.

Who it is for

For anyone who wants not just to reach old age but to meet it strong and clear-headed. And for anyone tired of contradictory health advice who wants to know what actually matters.

Exercise is by far the most potent longevity “drug.”

The surgeon who was tired of arriving too late

Peter Attia trained as a surgeon at Johns Hopkins, one of the best hospitals in America. And again and again he saw the same picture. People came to him when the disease was already far along: the tumor had spread, the arteries of the heart were nearly closed. All medicine could do at that point was buy a little time. Attia began asking himself an awkward question: why do we step in so late, when these diseases grow inside a person for years?

In the end he left surgery and turned to what he calls longevity medicine. He wrote Outlive with the journalist Bill Gifford. It came out in 2023 and became a worldwide bestseller. It is not a list of tips, and it does not promise eternal youth. It is a doctor's attempt to explain how the diseases that kill us work, and where we have levers.

The book's main idea is simple. The goal is not to live as many years as possible at any cost. The goal is for your last years to be years of strength, a clear mind and joy, not a long fading away. To get there, Attia believes, you have to think about old age at thirty, forty and fifty, not at eighty.

In the pages ahead, you will learn which four diseases take most lives, why centenarians get the same diseases as everyone else, and why the author ranks physical fitness above any pill. And at the end, what makes a long life worth living.

Fast death retreated, slow death stayed

Just a hundred years ago, people most often died fast. An infection, a wound or a hard childbirth could end a life in a few days. Attia calls this fast death. Hygiene, vaccines and antibiotics have nearly defeated it in rich countries.

Slow death took its place. Today most people die of one of four diseases that Attia calls the Four Horsemen. They are heart and blood vessel disease, cancer, neurodegenerative diseases such as Alzheimer's, and type 2 diabetes along with other metabolic disorders.

All four share one trait: they develop quietly. A person feels healthy, passes routine blood tests, and all the while the process goes on. By the time the first symptoms appear, the disease has usually been developing for many years.

They share a second trait too. In the author's view, the Horsemen are linked to one another through metabolism. A metabolism that works poorly raises the risk of not one disease but several at once. So Attia suggests not fighting each Horseman separately, but strengthening what they have in common.

Read in Livria

About the author

Peter Attia is a Canadian-born American physician who trained at Stanford and at Johns Hopkins Hospital. He practices longevity medicine and hosts a popular podcast. Bill Gifford is a journalist who writes about the science of aging.

All books by this author: Peter Attia, Bill Gifford

Terms from the book

  • Insulin
  • Rosenberg
  • dementia
  • Stephanie
  • aneurysm
  • Healthspan
  • O’Connor
  • Alzheimer's
  • Four Horsemen
  • diabetes
  • Hippocrates
  • Atherosclerosis
  • Johns Hopkins: Johns Hopkins Hospital in Baltimore, one of the leading university hospitals in the United States, where Attia trained in surgery.
  • Gifford: Bill Gifford, an American journalist who writes about the science of aging, and the book's co-author.
  • neurodegenerative: Diseases in which nerve cells gradually die, such as Alzheimer's or Parkinson's disease.
  • clinical trials: Testing a treatment on people under strict rules, usually by comparing a group that gets the treatment with a group that does not.
  • Medicine 3.0: Attia's term, not an official one: medicine that assesses risk early and acts long before a diagnosis.
  • Barzilai: Nir Barzilai, an American researcher on aging at the Albert Einstein College of Medicine who studies centenarians.
  • Ashkenazi: The Ashkenazim are a Jewish community that historically lived in Central and Eastern Europe. The genetic closeness of its members makes it convenient to study.
  • Calment: Jeanne Calment (1875 to 1997), a Frenchwoman who lived to 122, the longest confirmed human lifespan.
  • insulin resistance: A state in which tissues respond weakly to insulin. It often comes before type 2 diabetes.
  • fatty liver disease: A buildup of fat in liver cells that is not caused by alcohol. It can go without symptoms for a long time.
  • lipoprotein(a): A particle in the blood that carries cholesterol. Its level is almost entirely set by genes, and a high level raises the risk of heart disease.
  • apolipoprotein B: A protein on the surface of the particles that carry cholesterol into the vessel walls. Its amount tells you how many of those particles there are.
  • melanoma: A malignant tumor that grows from the pigment cells of the skin.
  • Immunotherapy: A cancer treatment that helps turn a person's own immune system against the tumor.
  • APOE: A gene with a variant, e4, that markedly raises the risk of Alzheimer's disease, especially when two copies are inherited.
  • VO2 max: The largest amount of oxygen the body can use during all-out effort. The main measure of endurance.
  • Zone 2: Moderate effort at which you can still talk, but only just. Attia puts it at the center of endurance training.
  • Centenarian Decathlon: An idea from the book: a list of things you want to be able to do in deep old age, and training aimed at them.

All terms

Similar books